Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 Viatris Inc. (Nasdaq: VTRS) will report second quarter 2025 financial results on Thursday, August 7, 2025. Company executives will host a webcast at...

Key Takeaway: Viatris Inc. (Nasdaq: VTRS) will announce its second quarter 2025 financial results on August 7, 2025. The announcement will be followed by a webcast hosted by company executives to discuss the outcomes. Investors and the public can participate in the webcast via the company's investor website or through a conference call. Viatris promotes its role in providing healthcare by connecting generic and brand medicines, emphasizing its global reach and diverse portfolio.
Price reaction · baseline $8.98 (2025-06-11 close) · hit after-hours · clean, no other VTRS news in the window
day 0 close · peak
+1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is set to report its financial results, indicating ongoing operational transparency.
  • The company continues to bridge the gap between generics and branded medicines, highlighting its unique position in the market.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH , June 12, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS ) will report second quarter 2025 financial results on Thursday, August 7, 2025 . Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris Viatris Inc. (Nasdaq: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X .

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris release its Q2 2025 financial results?

Viatris will report its second quarter 2025 financial results on August 7, 2025.

What time is the Viatris earnings call scheduled?

The earnings call is set for 8:30 a.m. ET on August 7, 2025.

How can I listen to the Viatris earnings call?

You can listen via webcast at investor.viatris.com or by phone at 844.308.3344.

Is there a replay available for the earnings call?

Yes, a replay of the webcast will be accessible on the Viatris website.

What is the mission of Viatris Inc.?

Viatris aims to empower people globally to live healthier at every life stage.

Last updated: Jun 12, 2025